logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

Definition of "persistent absence" to change

13 July 2011

The Department for Education announced on Tuesday that they are to reduce the threshold at which a pupil is defined as “persistently absent” from 20% to 15% in an attempt to solve truancy in schools. This reduction in the threshold is set to incorporate an additional 246,000 pupils but the move has been criticised by unions for failing to tackle the root cause of truancy.

On a practical level, the reduction in the threshold will impact on Ofsted’s evaluation of pupil attendance, and in some cases this could result in a lower grade. Ofsted has advised that they will explore ways of taking into account the lower threshold within the new framework expected early next year.

The government’s attempts to tackle truancy are unlikely to stop here. Nick Gibb has advised that in the coming months stronger powers for schools to deal with truancy will be announced. It remains to be seen whether these changes will actually deter persistent absences in schools.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up